Association Between Anthropometric Parameters and Measurements of Liver Stiffness by Transient Elastography

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 3, 2013, Pages

  Wong, Grace Lai Hung ^a   Chan, Henry Lik Yuen ^a   Choi, Paul Cheung Lung ^a   Chan, Anthony Wing Hung ^a   Lo, Angeline Oi Shan ^a   Chim, Angel Mei Ling ^a   Wong, Vincent Wai Sun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biopsy; Body Mass Index; Cirrhosis; Liver Fibrosis; Nonalcoholic Fatty Liver Disease; Waist Circumference

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HUMAN; LIVER BIOPSY; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; RIGIDITY; WAIST CIRCUMFERENCE;

EID: 84874562638     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.09.025     Document Type: Article

References (34)

1. Wong V.W., Chan H.L. Transient elastography. J Gastroenterol Hepatol 2010, 25:1726-1731.
2. Chan H.L., Wong G.L., Choi P.C., et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009, 16:36-44.
3. Castéra L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
4. Wong V.W., Vergniol J., Wong G.L., et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010, 51:454-462.
5. Liaw Y.F., Leung N., Kao J.H., et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008, 2:263-283.
6. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
7. Wong V.W., Wong G.L., Choi P.C., et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010, 59:969-974.
8. Wong V.W., Chu W.C., Wong G.L., et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012, 61:409-415.
9. Castéra L., Foucher J., Bernard P.H., et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010, 51:828-835.
10. Wong G.L., Wong V.W., Chim A.M., et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol 2011, 26:300-305.
11. Abenavoli L., Beaugrand M. Transient elastography in non-alcoholic fatty liver disease. Ann Hepatol 2012, 11:172-178.
12. Das K., Sarkar R., Ahmed S.M., et al. "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. Hepatology 2012, 55:584-593.
13. Finucane M.M., Stevens G.A., Cowan M.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
14. Wong G.L., Wong V.W., Choi P.C., et al. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography. Am J Gastroenterol 2008, 103:3071-3081.
15. Wong G.L., Wong V.W., Choi P.C., et al. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2009, 24:1002-1007.
16. Gaia S., Carenzi S., Barilli A.L., et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011, 54:64-71.
17. Lupsor M., Badea R., Stefanescu H., et al. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointest Liver Dis 2010, 19:53-60.
18. Nobili V., Vizzutti F., Arena U., et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008, 48:442-448.
19. Yoneda M., Yoneda M., Mawatari H., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008, 40:371-378.
20. Wong V.W., Wong G.L., Tsang S.W., et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011, 60:829-836.
21. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
22. Chan H.L., de Silva H.J., Leung N.W., et al. How should we manage patients with non-alcoholic fatty liver disease in 2007?. J Gastroenterol Hepatol 2007, 22:801-808.
23. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163. WHO Expert Consultation.
24. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
25. Wong G.L., Wong V.W., Choi P.C., et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009, 58:111-117.
26. Brunt E.M., Janney C.G., Di Bisceglie A.M., et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
27. Wong G.L., Wong V.W., Choi P.C., et al. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. Clin Gastroenterol Hepatol 2009, 7:227-233.
28. Wong G.L., Wong V.W., Choi P.C., et al. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther 2011, 16:165-172.
29. Roulot D., Costes J.L., Buyck J.F., et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011, 60:977-984.
30. Wong G.L., Wong V.W., Chan H.L. Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease?. J Hepatol 2011, 55:497. author reply 498.
31. Roulot D., Czernichow S., Le Clésiau H., et al. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008, 48:606-613.
32. Saadeh S., Younossi Z.M., Remer E.M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-750.
33. Wong V.W., Wong G.L., Chu W.C., et al. Hepatitis B virus infection and fatty liver in the general population. J Hepatol 2012, 56:533-540.
34. de Lédinghen V., Wong V.W., Vergniol J., et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan(R). J Hepatol 2012, 56:833-839.